Cardiff Oncology, Inc. Common Stock (NASDAQ: CRDF) last traded at $1.08, up 1.89% on the session. The quote above updates while this page is open; the figures below are drawn from Cardiff Oncology, Inc. Common Stock’s own filings and are restated only when a new one is published.
Cardiff Oncology, Inc. Common Stock trades on NASDAQ under the ticker CRDF. Its market capitalisation is $84.02 million.
Valuation measures for Cardiff Oncology, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $84.02M |
|---|---|
| Enterprise value | $85.62M |
| Price / sales | 165.39 |
| Price / book | 3.17 |
| Beta | 1.78 |
Trailing-twelve-month figures tagged in Cardiff Oncology, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $508.0K |
|---|---|
| Net income (TTM) | -$40.05M |
| EPS (TTM) | -$0.600 |
| Operating margin | -8320.08% |
| Return on equity | -150.95% |
| Cash | $9.20M |
Range and volume for CRDF over the past 52 weeks.
| 52-week high | $3.31 |
|---|---|
| 52-week low | $0.760 |
| Volume | 298.1K |
| Average volume | 1.03M |
| Previous close | $1.06 |
Invest a chosen dollar amount in Cardiff Oncology, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CRDF.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.